대한부인종양학회

최신 논문

총 게시글 : 35

PD-L1-Expression in primary and recurrent vulvar squamous cell cancer 2025-03-20 VIEW : 32
Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study 2025-03-20 VIEW : 10
What happens after menopause? (WHAM): A prospective controlled study of cognition 24 months after premenopausal risk-reducing salpingo-oophorectomy 2025-03-20 VIEW : 9
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan 2024-09-24 VIEW : 9
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study 2024-09-24 VIEW : 13
Choosing the right adjuvant therapy for stage III–IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy 2024-09-24 VIEW : 1
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis 2024-09-24 VIEW : 3
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies 2024-06-26 VIEW : 5
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses 2024-06-26 VIEW : 4
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study 2024-03-29 VIEW : 9
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres 2024-03-29 VIEW : 5
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial 2023-12-26 VIEW : 54
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer 2023-12-26 VIEW : 9
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres 2023-09-19 VIEW : 43
Intrauterine manipulator during hysterectomy for endometrial cancer: a systematic review and meta-analysis of oncologic outcomes. 2023-09-19 VIEW : 21

1
2
3